PremiumThe FlyInspireMD price target lowered to $4 from $4.50 at Piper Sandler InspireMD Inc. Reports Q1 2025 Financial Results InspireMD Inc’s Earnings Call: Growth Amid Challenges PremiumCompany AnnouncementsInspireMD Inc. Reports 2024 Financial Results and Strategic Progress InspireMD’s Earnings Call: Cautious Optimism Amid Challenges InspireMD reports Q4 EPS (19c) vs (16c) last year PremiumThe FlyInspireMD announces inducement grants under Nasdaq listing rule InspireMD announces inducement grants InspireMD CFO Retirement Amid Strategic Transition